SEMA6C and cancer: Moreover, the overexpression of Sema6C ectodomain in cancer cells did not replicate the phenotypic changes elicited by transmembrane Sema6C, likely implicating reverse signaling mechanisms triggered by the intracellular tail, that were never investigated previously for this semaphorin.